Key result
Nitrendipine treatment for 5 weeks reduced clinic supine blood pressure from 152/96 to 134/84 mm Hg and attenuated pressor responses to norepinephrine but not to angiotensin II.
Why the study?
Does nitrendipine alter systemic pressor responses to norepinephrine and angiotensin II in subjects with mild, uncomplicated hypertension?
RCT (n=11)
Does nitrendipine alter systemic pressor responses to norepinephrine and angiotensin II in subjects with mild, uncomplicated hypertension?
Answers are grounded in this paper and cite their sources.
The effect of long-term treatment with nitrendipine on systemic pressor responses to norepinephrine (NE) and angiotensin II (AII) was evaluated in 11 subjects with mild, uncomplicated hypertension. Pressor responses to NE and AII were measured at the end of a 4-wk placebo period and after 5 wk treatment with nitrendipine (final dose 16 mg twice daily; range 5 to 20 mg/day) or placebo. In subjects who received nitrendipine, clinic supine blood pressure was reduced from 152 +/- 12/96 +/- 4 mm Hg to 134 +/- 11/84 +/- 5 mm Hg and pressor responses to NE but not to AII were attenuated. Endogenous plasma levels of NE and renin activity were not changed by nitrendipine. Data suggest that noradrenergic blood pressure control mechanisms depend more on cellular calcium transport than do AII-mediated ones and may help explain the greater effectiveness of calcium entry blockers in the treatment of low-renin hypertension.
No takes yet. Share an insight, caveat, or question.
Simon et al. (1984) conducted an RCT in mild, uncomplicated hypertension (n=11). Nitrendipine vs. Placebo was evaluated on Systemic pressor responses to norepinephrine (NE) and angiotensin II (AII) and clinic supine blood pressure. Nitrendipine treatment for 5 weeks reduced clinic supine blood pressure from 152/96 to 134/84 mm Hg and attenuated pressor responses to norepinephrine but not to angiotensin II.
Synapse has enriched 10 related papers. Consider them for comparative context: